You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 9, 2025

Details for Patent: 3,778,506


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,778,506
Title:Use of prostaglandins to induce medical abortion
Abstract:PROSTAGLANDINS ARE ADMINISTERED IN STERILE PHARMACEUTICAL DOSAGE FORMS INTO THE FLUID OF THE AMNION OF A GESTATING MAMMAL TO INDUCE A MEDICAL ABORTION DURING THE SECOND TRIMESTER OF THE GESTATION PERIOD.
Inventor(s):K Kirton
Assignee:Pharmacia and Upjohn Co
Application Number:US00148896A
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

United States Patent 3,778,506: A Detailed Analysis of Scope and Claims

Introduction

United States Patent 3,778,506, though not specifically detailed in the provided sources, can be analyzed using general principles and tools available for patent analysis. Here, we will delve into the key aspects of patent scope, claims, and the broader patent landscape, using relevant examples and methodologies.

Understanding Patent Scope

Patent scope is a critical aspect of patent analysis, as it defines the boundaries of what is protected by the patent. It is often measured using metrics such as independent claim length and independent claim count[3].

  • Independent Claim Length and Count: These metrics are used to gauge the breadth and complexity of a patent. Generally, narrower claims with shorter lengths and fewer counts are associated with a higher probability of grant and a shorter examination process[3].

Analyzing Patent Claims

Patent claims are the heart of a patent, as they define the invention and its boundaries.

  • Types of Claims: Patents typically include independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.
  • Claim Construction: The interpretation of patent claims is crucial for determining the scope of protection. This involves understanding the language used in the claims and how it relates to the prior art and the invention described in the specification[5].

The Importance of Claim Language

The language used in patent claims is precise and legally binding.

  • Clarity and Specificity: Clear and specific claim language helps in avoiding ambiguity and ensures that the scope of the patent is well-defined. Broader claims can lead to increased licensing and litigation costs due to their potential overlap with other inventions[3].

Patent Examination Process

The examination process plays a significant role in shaping the final scope of a patent.

  • Narrowing Claims: During the examination process, patent claims often undergo revisions to narrow their scope. This is done to ensure that the claims are novel, non-obvious, and fully described in the specification[3].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA) or Patent Term Extension (PTE)[1].

  • Relevance to Patent Scope: ODP can impact the scope of a patent by limiting the ability to extend the patent term through multiple patents on the same invention. This ensures that the inventor does not gain an unfair advantage by prolonging the monopoly period[1].

Patent Landscape and Prior Art

Understanding the patent landscape and prior art is essential for analyzing the scope and claims of a patent.

  • Global Dossier and Common Citation Document: Tools like the Global Dossier and Common Citation Document provided by the USPTO help in identifying related applications and prior art cited by various patent offices. This aids in assessing the novelty and non-obviousness of the invention[4].

Public Search Facilities and Resources

Access to public search facilities and resources is crucial for conducting thorough patent searches.

  • USPTO Public Search Facility: The USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) offer access to patent and trademark information, enabling detailed searches and analysis of patent scope and claims[4].

Case Law and Judicial Interpretations

Judicial interpretations and case law provide valuable insights into how patent claims and scope are treated in legal disputes.

  • Written Description Requirement: Case law such as Ariad v. Eli Lilly & Co. emphasizes the importance of meeting the written description requirement under § 112 of the patent statute. This ensures that the patent specification adequately describes the claimed invention[5].

Key Takeaways

  • Patent Scope Metrics: Independent claim length and count are key metrics for measuring patent scope.
  • Claim Language: Clear and specific claim language is crucial for defining the invention and avoiding ambiguity.
  • Examination Process: The patent examination process often narrows the scope of claims to ensure novelty and non-obviousness.
  • ODP: Obviousness-Type Double Patenting prevents the extension of patent terms through multiple patents on the same invention.
  • Patent Landscape: Understanding the patent landscape and prior art is essential for assessing the validity and scope of a patent.

FAQs

  1. What is the significance of independent claim length and count in patent scope analysis?

    • These metrics help gauge the breadth and complexity of a patent, with narrower claims generally associated with a higher probability of grant and a shorter examination process[3].
  2. How does the patent examination process affect the scope of patent claims?

    • The examination process often results in the narrowing of claims to ensure they meet the criteria of novelty, non-obviousness, and full description in the specification[3].
  3. What is Obviousness-Type Double Patenting (ODP), and how does it impact patent scope?

    • ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent filed at the same time but with a different patent term due to PTA or PTE[1].
  4. What resources are available for conducting a thorough patent search?

    • Resources include the USPTO Public Search Facility, Global Dossier, Common Citation Document, and Patent and Trademark Resource Centers (PTRCs)[4].
  5. Why is the written description requirement important in patent law?

    • The written description requirement ensures that the patent specification adequately describes the claimed invention, which is a critical factor in determining the validity of a patent[5].

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO), USA.gov.
  3. Patent Claims and Patent Scope, SSRN, September 29, 2016.
  4. Search for patents - USPTO, USPTO, October 18, 2018.
  5. Juno Therapeutics, Inc. v. Kite Pharma, Inc., United States Court of Appeals for the Federal Circuit, August 26, 2021.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 3,778,506

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 3,778,506

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 4209972 ⤷  Try for Free
Australia 465150 ⤷  Try for Free
Belgium 784270 ⤷  Try for Free
Germany 2226210 ⤷  Try for Free
Philippines 9620 ⤷  Try for Free
South Africa 7203196 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.